The SCRIM score: a clinical tool for cancer risk-stratification in patients with idiopathic inflammatory myopathy. [PDF]
Kim YK +12 more
europepmc +1 more source
Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells. [PDF]
Liu Y +14 more
europepmc +1 more source
Characterization of Muscle Tissue Cell Diversity and Clinical Implications in Idiopathic Inflammatory Myopathy. [PDF]
Zhu H +10 more
europepmc +1 more source
Correction: Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China. [PDF]
Li C +6 more
europepmc +1 more source
Quantitative spectral computed tomography biomarkers for idiopathic inflammatory myopathy-associated interstitial lung disease: a dual-layer detector computed tomography study. [PDF]
Zhang Y +5 more
europepmc +1 more source
Targeting B Cells for the Treatment of Idiopathic Inflammatory Myopathy. [PDF]
Liu T, Chen B, Yin G, Xie Q.
europepmc +1 more source
Identification of idiopathic inflammatory myopathy research cohorts using international classification of disease (ICD) codes: A systematic review. [PDF]
Allenzara A +4 more
europepmc +1 more source
Clinical Significance and Correlation of Plasma D-Dimer, Fibrinogen, and Cytokines in Idiopathic Inflammatory Myopathy. [PDF]
Jiang X, Shang L, Hou C.
europepmc +1 more source
Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China. [PDF]
Li C +6 more
europepmc +1 more source

